Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease

See also
Status	Clinical Trial	Phase
Completed	`NCT02057185` - Occupational Status and Hematological Disease
Active, not recruiting	`NCT02979522` - A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma	Phase 1/Phase 2
Completed	`NCT00540007` - Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma	Phase 2
Active, not recruiting	`NCT03755414` - Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation	Phase 1
Recruiting	`NCT01676805` - Tissue Collection for Studies of Lymph Cancer
Completed	`NCT02378337` - Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality	N/A
Terminated	`NCT00916045` - Pilot Study of Unrelated Cord Blood Transplantation	Phase 2
Completed	`NCT00534989` - Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT	N/A
Terminated	`NCT00393380` - Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor	Phase 2
Completed	`NCT00062868` - LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma	Phase 1
Completed	`NCT00388349` - Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease	Phase 2
Recruiting	`NCT05255601` - A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma	Phase 1/Phase 2
Completed	`NCT01716806` - A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)	Phase 2
Active, not recruiting	`NCT04998331` - A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin
Completed	`NCT02389101` - Molecular and Whole-body MR Imaging in Lymphomas	N/A
Completed	`NCT00871702` - Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease	Phase 1
Recruiting	`NCT02589548` - Brazilian Prospective Hodgkin Lymphoma Registry
Completed	`NCT00398411` - Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells	Phase 3
Terminated	`NCT00514722` - Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies	N/A
Terminated	`NCT00225173` - Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease	Phase 2

NCT number	NCT00038558
Study type	Interventional
Source	M.D. Anderson Cancer Center
Contact
Status	Completed
Phase	Phase 3
Start date	November 2001
Completion date	March 2005

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms